PCMT interacts with the carboxymethylation of the tumor suppressor protein p53 at residues 29 and 30 of isoaspartate and downregulates its expression, thereby inhibiting the anoikis of tumor cells and promoting tumor development (128). This evidence concerns the gene TP53 and neoplasm.